Trials in Philadelphia, Pennsylvania
Here are the top 10 medical studies for prostate cancer in Philadelphia, Pennsylvania
Popular Filters
Phase 3 Trials
AKT Inhibitor
Capivasertib + Docetaxel for Prostate Cancer
Recruiting1 awardPhase 3
Philadelphia, Pennsylvania
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
18F-labeled PET Imaging for Prostate Cancer
Recruiting2 awardsPhase 3
New York, New York
This trial at NYU Langone Health tests prostate specific antigen (PSA) levels after Radical Prostatectomy to identify disease recurrence, aiming to identify and treat early. Patients with positive findings will be offered salvage intervention.
Hormone Therapy
Relugolix vs Leuprolide for Prostate Cancer
Recruiting2 awardsPhase 3
Bala-Cynwyd, Pennsylvania
This trial compared the safety and heart-related risks of two hormone-lowering medications, relugolix and leuprolide acetate, in adults with prostate cancer. These drugs help manage cancer by reducing testosterone levels. The study was discontinued, but patients can continue their treatment for a certain period. Relugolix is the first oral medication of its kind and was approved by the FDA based on previous study results.
Androgen Receptor Inhibitor
Darolutamide + ADT for Prostate Cancer
Recruiting1 awardPhase 3
Bala-Cynwyd, Pennsylvania
This trial is researching if a combination of ADT and darolutamide can help men with prostate cancer at high risk of biochemical recurrence (BCR) live longer without their cancer getting worse.
Trials With No Placebo
Hormone Therapy
Abiraterone/Enzalutamide/Apalutamide for Prostate Cancer
Recruiting3 awardsPhase 2
Bronx, New York
This trial looked at how well two different drugs work in people with a certain kind of cancer. The drugs worked well, and the people who got them had better outcomes than people who didn't. The trial was done in a group of people who all have the same kind of cancer, and the results showed that the drugs worked well in this group.
Radioisotope Therapy
177Lu-rhPSMA-10.1 for Prostate Cancer
Recruiting1 awardPhase 1 & 2
New York, New York
This trial tests a new radioactive treatment for men with advanced prostate cancer that doesn't respond to hormone therapy. The treatment targets and kills cancer cells by delivering radiation directly to them. This new approach has shown promise in extending survival for men with advanced prostate cancer.
Behavioural Intervention
AGN-CognI.Q for Prostate Cancer
Recruiting1 awardPhase 1
Hershey, Pennsylvania
This trial is testing a herbal supplement from Angelica gigas Nakai root in prostate cancer patients with recurrent disease. The goal is to see how the body processes and reacts to the supplement, potentially delaying or avoiding further hormonal therapy. Angelica gigas Nakai root has been used in traditional medicine in Korea and has shown various bioactivities, including anticancer properties.
Androgen Receptor Antagonist
LAVA-1207 for Prostate Cancer
Recruiting1 awardPhase 1 & 2
New York, New York
This trial tests new treatments for advanced prostate cancer that doesn't respond to standard treatments. The treatments include a new drug, an immune system booster, and a medication that helps the immune system fight cancer.
Behavioural Intervention
Educational Media Interventions for Cancer
Recruiting1 award9 criteria
New York, New York
This trial is studying how well educational media interventions work in preparing Latinx Spanish-speaking patients for radiation therapy for breast or prostate cancer and in fostering receptivity to and informed decision-making around cancer clinical trial participation.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.